Section Saf-C 5918.01 - Agreement(a) The procurement, storage, and security of controlled prescription drugs shall be regulated in accordance with 21 CFR 1300.(b) The procurement, storage, and security of non-controlled prescription drugs shall be defined by the unit's MRH, in accordance with the NH patient care protocols.(c) Prior to obtaining possession of controlled drugs, each unit shall enter into a formal written agreement with its designated MRH.(d) A separate agreement between the unit and the designated local MRH shall be required for each unit and each of its applicable satellite locations based in this state.(e) The agreement shall identify and describe the policies and procedures that implement the provisions of Saf-C 5918.03 through Saf-C 5918.07 for the procurement, security, and accountability of controlled drugs and be routed as follows: (1) The signed agreement shall be forwarded to the director for approval and signature;(2) The director shall then forward the agreement to the Drug Enforcement Agency (DEA) Special Agent in Charge (SAC) for written approval;(3) The original approved agreement signed by the director and the DEA SAC shall be maintained, on file, in the pharmacy of the MRH; and(4) Copies of the approved agreement shall be kept on file at the unit and with the division.(f) Any revisions to the existing agreement, except for a change in identity of the UCDC or the MRH pharmacist pursuant to (l) below, shall necessitate a new agreement, which shall be approved by the director and the SAC.(g) Units shall conduct controlled drug activity pursuant to the provisions of 21 CFR 1304.03, as an extension of the MRH, DEA registration.(h) The signed, approved agreements shall be available for inspection, upon demand, by any person or agency charged with the responsibility of enforcing RSA 318 or RSA 318-B.(i) The division shall maintain a current listing of all units with signed agreements and provide copies to the pharmacy board either upon demand or as changes occur.(j) The agreement shall be typewritten or legibly printed and identify the following: (1) The legal name of the unit;(2) The street address of the unit;(3) The mailing address of the unit;(4) The business telephone number of the unit;(5) The FAX number of the unit, if available;(6) The E-mail address of the unit;(7) The legal name of the head of unit;(8) The identity of the UCDC and the person's provider license number;(9) The identity of the MRH;(10) The mailing address of the MRH;(11) The US Drug Enforcement registration number of the MRH; and(12) The identity of the MRH pharmacist.(k) The identity and quantities of controlled drugs contained in each drug kit and the total number of drug kit(s) for each unit shall be included in the agreement.(l) Any changes in the identity of the UCDC or MRH pharmacist shall require written notice to all parties in the agreement and the director within 5 days after making the change.N.H. Admin. Code § Saf-C 5918.01
(See Revision Note at chapter heading for Saf-C 5900) #8520, INTERIM, eff 12-16-05, EXPIRED: 6-14-06
New. #9779-A, eff 9-8-10
Amended by Volume XXXIX Number 24, Filed June 13, 2019, Proposed by #12790, Effective 5/24/2019, Expires 5/24/2029.